metabolic health – The Milli Chronicle

Sunday, April 5, 2026

Latest:

Factual Version of a Story

NewsDesk MC April 4, 2026 arranged marriages, bariatric care, clinics, cosmetic use, drug pricing, drug regulation, Eli Lilly, generics, healthcare market, india, India healthcare, Lancet study, lifestyle medicine, metabolic health, Mounjaro, Novo Nordisk, obesity, pharmaceuticals, pre-wedding trends, semaglutide, social pressure, Wegovy, weight loss drugs, wellness industry

India’s pre-wedding boom fuels demand for weight-loss injections despite regulatory concerns

“We understand the curiosity, but this cannot be a quick fix,” said Dr. Swati Pradhan, highlighting concerns over misuse of

Asia Health Latest Lifestyle News

Sumati Gupta Anand January 10, 2026January 10, 2026 body weight stigma, cardiovascular disease, chronic disease prevention, food environment, food industry regulation, global health, health policy, healthcare systems, healthy eating, lifestyle diseases, mental health and obesity, metabolic health, modern obesity crisis, non-communicable diseases, nutrition education, obesity, obesity and economy, obesity and society, obesity awareness, obesity causes, obesity epidemic, obesity prevention, obesity risk factors, obesity stigma, physical inactivity, preventive healthcare, processed foods, public health, public health crisis, sedentary lifestyle, type 2 diabetes, ultra-processed foods, unhealthy lifestyle, urban lifestyle, world health organization

Obesity: A Silent Epidemic of the Modern Age — A Growing Red Flag

Your body is your lifelong home—nourish it, move it, respect it. Obesity is often spoken of in the language of

Novo Nordisk Expands Weight-Loss Treatment Options with US Launch of Wegovy Oral Pill

The launch of Wegovy in pill form marks a major step in widening access to obesity treatment in the United

Asia Latest News

NewsDesk MC November 7, 2025November 7, 2025 Cipla, diabetes care India, diabetes control, diabetes treatment India, Eli Lilly, Eli Lilly India, GLP-1 drugs, healthcare growth India, healthcare technology, Hyderabad health innovation, India pharma market, medical innovation, metabolic health, Mounjaro, Novo Nordisk, obesity awareness, obesity treatment, pharmaceutical sales India, Wegovy, weight management therapy, weight-loss drug India, weight-loss injection

Eli Lilly’s Mounjaro Becomes India’s Top-Selling Drug, Signaling a New Era in Healthcare Innovation

Hyderabad – Eli Lilly’s groundbreaking weight-loss and diabetes treatment, Mounjaro, takes the top spot in India’s pharmaceutical market, marking a

Pfizer Strengthens Its Bid for Metsera, Reinforces Commitment to Innovation in Obesity Treatment

Pfizer’s strategic move to revise its bid for Metsera underscores its dedication to advancing next-generation obesity therapies and fostering competition